Abstract:Background: Releasing growth factor through controlled release system is one of the study directions of bioactive factor application. Objective: To prepare transforming growth factor β1 (TGF-β 1) loaded chitosan microspheres with ionically cross-linking precipitant method, and to study the properties of controlled release of TGF-β 1 and biocompatibility in vitro. Design, time and setting: An observational trial was performed in the central labotatory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Wuhan, Hubei, China) from October 2006 to September 2007. Materials: Chitosan, 90% deacetylation degree, was offered by Tsinghua University Chemical Engineering Department; TGF-β 1 was offered by Jingmei Biotech Co., Ltd.; Rats were offered by the Experimental Animal Center of Tongji Medical College, Huazhong University of Science and Technology. Methods: Chitosan microspheres were prepared with ionically cross-linking precipitant method, and TGF-β 1 was then packaged in the microspheres. After passage culture, myofibroblasts in descending thoracic aorta of rats at the adjusted concentration of 1× 10 8/L were added with chitosam microsphere leaching liquor (4, 2, 1 g/L), while the medium without leaching liquor was taken as controls. Main outcome measures: The features such as the size distribution, drug content, drug encapsulating and in vitro release were studied with scanning electron microscope, laser grainsize analyzer and ELISA method. MTT test was performed to observe cell proliferation and evaluate the biocompatibility in vitro. Results: The microspheres were spherical and smooth. The mean diameters of the spheres were 272 nm, and the high encapsulation efficiency was obtained, about 80.6%. The sudden release of TGF-β 1 was observed in the initial period in test of release in vitro, and then TGF-β 1 could be constantly released from the chitosan microspheres (27% in 24 hours and up to 41% in 7 days). MTT showed that the chitosan microspheres did not damage the cell growth in vitro, indicating good compatibility. Conclusion: The method to prepare chitosan microspherea with ionically cross-linking precipitant is convenient and feasible, and TGF-β 1 possesses good delayed release and compatibility.

The Preliminary Study of Temperature-Responsive Chitosan Gel Combined withDrug-Loaded Chitosan Microspheres

[Preparation of Alginate-Chitosan-poly (Lactic-Co-glycolic Acid) Composite Microsphere and Its Regulation of Protein Release].

Preparation and in vitro compatibility of transforming growth factor beta 1 loaded chitosan microspheres

In Vitro Study of TGF-β1 Loaded Chitosan Microspheres

Preparation and Drug Release Property of Sodium Alginate/Gelatin/Chitosan Blend Hydrogel Drug-loaded Microspheres

The dual release of baicalin and bovine serum albumin preparation and drug release performance testing

Influence of pH-responsive compounds synthesized from chitosan and hyaluronic acid on dual-responsive (pH/temperature) hydrogel drug delivery systems of Cortex Moutan

Drug delivery study of temperature-responsive chitosan/poly(N-isopropylacrylamide) semi-interpenetrating-polymer-network beads

Preparation of carboxymethylcellulose / ZnO / chitosan composite hydrogel microbeads and its drug release behaviour

Preparation and Properties of Crosslinked Chitosan Thermosensitive Hydrogel for Injectable Drug Delivery Systems

Preparation, Characterization And In Vitro Release Study Of Drug-Loaded Sodium Carboxy-Methylcellulose/Chitosan Composite Sponge

Preparation of Dual Crosslinked Alginate-Chitosan Blend Gel Beads and in Vitro Controlled Release in Oral Site-Specific Drug Delivery System

A Novel Thermo-Sensitive Hydrogel Based on Thiolated Chitosan/hydroxyapatite/beta-Glycerophosphate.

β-Tricalcium Phosphate-Loaded Chitosan-Based Thermosensitive Hydrogel for Periodontal Regeneration

PEG-g-chitosan thermosensitive hydrogel for implant drug delivery: cytotoxicity, in vivo degradation and drug release.

The Production of Transforming Growth Factor - Beta1 - Loaded Chitosan Microspheres and the Effect of Controlled Release of TGF - Β1

Physically Crosslinked Chitosan/αβ-Glycerophosphate Hydrogels Enhanced by Surface-Modified Cyclodextrin: an Efficient Strategy for Controlled Drug Release.

Preparation and performance of chitosan/cyclodextrin-g-glutamic acid thermosensitive hydrogel

A Thermoresponsive injectable drug delivery system of chitosan/β-glycerophosphate with gellan gum/alginate microparticles

Preparation and Release Behavior of Chitosan Scaffolds Encapsulating Proteins Loaded in PLGA Microspheres

PEG-g-chitosan thermosensitive hydrogel for implant drug delivery: cytotoxicity,<i>in vivo</i>degradation and drug release